Bone-Directed Expression of Col1a1 Promoter-Driven Self-Inactivating Retroviral Vector in Bone Marrow Cells and Transgenic Mice

This publication has 29 references indexed in Scilit:

• Targeted Overexpression of Insulin-Like Growth Factor I to Osteoblasts of Transgenic Mice: Increased Trabecular Bone Volume without Increased Osteoblast Proliferation¹
  Endocrinology, 2000
• Amelioration of Retroviral Vector Silencing in Locus Control Region β-Globin-Transgenic Mice and Transduced F9 Embryonic Cells
  Journal of Virology, 1999
• Gene therapy - promises, problems and prospects
  Nature, 1997
• Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
  Proceedings of the National Academy of Sciences, 1995
• Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation
  Blood, 1994
• Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.
  Proceedings of the National Academy of Sciences, 1994
• Generation of a Transgenic Model for Retrovirus-Mediated Gene Therapy for Hepatocellular Carcinoma Is Thwarted by the Lack of Transgene Expression
  Human Gene Therapy, 1993
• Histopathology Associated with Elevated Levels of Growth Hormone and Insulin-Like Growth Factor I in Transgenic Mice*
  Endocrinology, 1989
• Growth Enhancement of Transgenic Mice Expressing Human Insulin-Like Growth Factor I*
  Endocrinology, 1988
• Infectivity and methylation of retroviral genomes is correlated with expression in the animal
  Cell, 1981